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Abstract
Background: Early diagnosis and treatment (EDAT) is crucial to reducing the burden of malaria in low-income
countries. In the Lao PDR, this strategy was introduced in 2004-2005 and an assessment was performed at the
community level in January 2007.
Methods: EDAT with malaria rapid diagnostic test (MRDT) and artemisinin combination therapy (ACT) was
prospectively assessed among 36 randomized village health volunteers (VHVs) and 720 patients in six malaria-
endemic provinces of Laos (three pilot provinces (PP), and three non-pilots provinces (NPP)). ACT was also
retrospectively assessed among 2188 patients within the same areas from June to November 2006. Two checklists
were used and scores were calculated.
Results: EDAT performance of the VHVs was rated better in PP than in NPP (16.67% versus 38.89%, respectively,
p = 0.004). Nearly all VHVs could diagnose malaria but only 16 (44%) could describe the symptoms of severe
malaria. In January 2007, 31/720 (4%) patients tested positive using the Paracheck® test, 35 (5%) with microscopy
(sensibility: 74.3%, specificity 99.3%, positive and negative predictive values: 83.9% and 98.7%, respectively). Patients
from June to November were at higher risk of malaria: 35.19% of 2,188 febrile patients were positive (OR: 10.6, 95%
CI: 7.4-15.5, p < 0.000). VHVs reported the MRDT easy to use, and yielded a satisfactory performance score. EDAT
performance was rated as poor despite satisfactory results regarding ACT treatment, duration and dosages.
Pre-referral treatment of severe malaria was infrequent and often inadequate, with 20% of these patients dying.
Results suggest a higher mortality from severe malaria than officially reported. Shortage of ACT was frequent.
Discussion and conclusion: MRDT and ACT are useful and efficient and can be used by VHVs. VHVs’ global EDAT
performance is enhanced through training and monitoring. Persistent gaps in knowledge, care of patients and
wrong treatment have to be addressed.
Background
Half of the world’s population is at risk of malaria, and
among the 243 million clinical cases every year, the
majority occurs in the world’s poorest countries [1].
This is not an inevitable burden. In the past decade,
there have been considerable advances in the cost-effec-
tiveness of preventing and treating malaria, together
with an increasing commitment from donors
and affected countries to combat this disease. However,
life-saving measures continue to be beyond the reach of
the majority of people who need them. Among strate-
gies, early diagnosis and treatment (EDAT) has been
recommended [2].
In the Lao People’s Democratic Republic (Lao PDR),
with a current estimated population of 6 million, malaria
is considered endemic throughout the country. However,
intensity of transmission varies between different ecologi-
cal areas ranging from 0.001 to 32.7 per thousand
infected bites and according to the seasons [3]. Around
60% of the population is estimated at risk [3].
After reports of increasing resistance to chloroquine
and sulphadoxine-pyrimethamine, the national malaria
treatment guidelines were changed to artemisinin-based
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Coartem®) in 2004 [4-6] and malaria rapid diagnostic
t e s t s( R D T )w e r ei n t r o d u c e d .T h i se a r l yd i a g n o s i sa n d
treatment (EDAT) strategy was initially implemented
in early 2005 at the village and health centre level in
three pilot provinces (PP) (Sekong, Saravan and Atta-
peu) covering a total of six districts and 60 villages.
Two village health volunteers (VHVs) per village were
selected and trained. Following the pilot phase, EDAT
was adopted as a national strategy and extended to all
17 provinces.
An evaluation of a short training on MRDT procedure
of 64 VHVs had shown a good reliability in 2003 [7].
However, previous studies indicated that RDT accuracy
was highly user-dependent despite its apparent simpli-
city. Basic diagnostic tests risked being performed and
interpreted poorly, but by providing simple and clear
instructions these errors could be reduced, thus increas-
ing their accuracy from 70% to 80% [8].
This study was conducted more than one year after
the initial expansion of the EDAT strategy in six ende-
mic provinces of Lao PDR. Its objective was to evaluate
the effects of training initiated in the three pilot areas in
2005 compared to the training in the expanded phase
for non-pilot provinces: performing an RDT test, its
interpretation and prescribing behaviour of the malaria
volunteers.
Methods
Malaria in the Lao PDR
In 2009, only five deaths among 22 784 confirmed cases
of malaria were reported compared with 600 deaths and
70 000 confirmed cases in 1997 [9]. The mortality rate
declined over the past 10 years from 0.12 per thousand
in 1996 to 0.01 in 2006. Anopheles dirus, Anopheles
minimus and Anopheles maculatus are the main vectors,
and Anopheles jeyporiensis and Anopheles nivipes the
secondary ones [10]. The National Malaria Control Pro-
gramme (NMCP) is based on Roll Back Malaria strate-
gies. The main preventive strategy is the use of
insecticide-treated nets (ITN) [9]. By 2007, operational
coverage of ITN was estimated to reach half of the
population at risk. RDT and ACT are provided free of
charge through the public health facilities [9].
Malaria village health volunteers
T h ev i l l a g eh e a l t hv o l u n t e e r s( V H V s )c o n s t i t u t et h e
most peripheral level of the public health care system in
Lao PDR. Volunteers provide primary health care ser-
vices, including diagnosis and management of basic dis-
eases (respiratory diseases, diarrhoea, and uncomplicated
malaria) as well as performing health education, assist in
vaccination campaigns and insecticide treatment of bed-
nets, and reporting of morbidity and mortality data to
health or district health offices [3]. VHVs (not malaria-
specific volunteers but primary health care workers) are
selected by the village committee in consultation with
villagers, the Community Health and the District Health
Office. Selection is based on pre-determined criteria.
Often the criteria cannot be met and the best person for
the role is selected. Each village is required to have two
volunteers. But there is often only one person who has
the literacy skill to be a VHV in rural areas.
VHVs play a pivotal role in malaria control:
￿ Village data collection
￿ Monthly reports to health centre
￿ Health education and community mobilization
campaigns
￿ Diagnosis and treatment
￿ Distribution and re-dipping of ITN [11].
Training of VHVs on EDAT
The EDAT strategy was first introduced in 20 villages/
districts of three districts of the three pilot provinces in
2005. The training covered both health staff at district
hospitals, health centres within the catchment areas of
the target villages and VHVs (2 per village). The training
was done mainly with trainers and facilitators from the
central level. In subsequent years, between 2006 and
2008, the national programme gradually scaled up the
coverage of RDTs and ACTs to more provinces, dis-
tricts, health centres and villages. The cascade training
involved trainers and facilitators from provincial level
who attended training of trainers’ sessions organized at
the central level. The VHVs training took place over
three days, which also included training in ITN distribu-
tion and use. In some provinces, pre- and post-tests
were done although results of these were not available
to the authors.
Cross sectional study
Due to budgetary issues and time constraints, a cross
sectional study was performed in six provinces from
January to February 2007. The first three pilot provinces
(PP) (Sekong, Saravan, Attapeu) were selected. Of the
14 other provinces in the country, three other non-pilot
provinces (NPP) (Luangnamtha, Savanakhet and
Champassak) were selected because nationally they had
the highest retrospective incidence of malaria (Figure 1).
Then a two-stage random sample procedure was
applied. One district per province and six villages in
each district were selected to make up a total of 36
villages.
The total population of the six provinces was 2.1 mil-
lion. Of these, 10 200 (4.8%) and 11 700 (5.5%) people
respectively, were suspected of, or confirmed with
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village level, VHVs were included in this survey if they
had been trained on ACT/RDT with the malaria pro-
gramme, had more than six months experience and, if
ACT/RDT was theoretically available in the village,
according to the provincial distribution list. In each vil-
lage one out of the two VHVs was selected using a ran-
dom table. A pretested questionnaire was used to assess
the characteristics of VHVs, their knowledge of malaria,
and to provide basic information on their activities
related to patients and malaria.
The quality of practice of VHVs was assessed by
observation performed by the investigators. Two check-
lists were used and scores were calculated as previously
described [2,7]. Briefly:
- A standardized 18-item form with four sections (his-
tory, patient care, observation of diagnosis and treat-
ment, information and advice) to evaluate the VHVs
practice (Table 1). Each item was given one point. The
score of VHVs practice was defined as: excellent >80%
of total score, good: 60-80%, poor <60%.
- A checklist of 15 criteria to evaluate the RDT perfor-
m a n c e( T a b l e1 ) .T h et o t a lo fg o o dr e s p o n s e ss c o r e d
was 15. Using the checklist, observers noted whether the
VHVs performed the steps correctly (= 1), incorrectly or
did not perform it (= 0). The score for RDT was defined
as bad = <5; insufficient = 5 - 10; good = 10 - 13; excel-
lent = >13.
All villagers with symptoms potentially related to
malaria were enrolled, with a minimum of 20 cases per
Figure 1 Study sites and annual parasite incidence in Laos. Adapted from 2004 CMPE data. Red is pilot provinces, blue is non pilot
provinces.
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home, if they had a history of fever of 2-3 days duration,
and no history of anti-malarial therapy during the pre-
vious week.
Laboratory testing
A finger-prick blood sample was collected from each
case to prepare thick and thin smears, and for RDT.
A maximum of 20 tests was recorded per VHV. RDT
tests were performed at the volunteer’s house. All RDT
results were confirmed by one expert reader of the
investigation team on site. The Paracheck® Pf Rapid
One Step device for Plasmodium falciparum histidine
rich protein (Orchid Biomedical Laboratories, Goa,
India) was used according to a previously described pro-
cedure [8].
Thick and thin blood films were made immediately
after blood collection and stained with 10% Giemsa for
ten minutes. Slides were further read by two expert
microscopists at the Centre of Malariology, Parasitology
and Entomology (CMPE) in Vientiane. All microscopists
were unaware of the results of the RDT tests. A mini-
mum of 200 consecutive fields was counted in the thick
blood film before classifying a slide as negative. Parasites
in thick blood films were counted against 200-500 white
blood cells. The parasite density was estimated for 8,000
white blood cells. If malaria parasites were seen, species
were identified, based on their morphological features
on the associated thin smear. The microscopic reading
at the CMPE was considered the gold standard. RDTs
were, as possible, performed according to the VHVs
normal practice. In fact, some more patients came when
they heard of a medical team doing tests.
Retrospective study
Anti-malarial prescriptions were retrospectively assessed
by checking the VHVs’ register books for the period
June - November 2006.
Data management and analysis
Data was entered in Epidata 3.1 freeware (Odense,
Denmark) and cross-checked against original data
sheets. Analysis was carried out with Stata, Version 8
(Stata Corporation, College Station, TX, USA). Fisher’s
exact test was used to assess associations between cate-
gorical variables, and Student’s t-test for two normally
Table 1 Score of VHVs care of RDT positive patients in Laos
Non pilot area
n=7
Pilot area
n=2 4
p Total
n=3 1
Score
%
Disease history score 13 73 0.43 86 29
1. How many people have a fever in your family? 1 3 4 13
2. Where did you go when you were febrile? 1 1 2 6
3. Duration of fever (days) 2 9 11 35
4. Did you have other symptoms? 2 6 8 26
5. What did you do/Which medicine did you take? 1 6 7 23
6. Explain the treatment (dosage) 4 24 28 90
7. Period of treatment (duration/length) 2 24 26 84
Patient’s care score 16 62 0 78 26
8. Inform on the disease 2 9 11 35
9. Inform on malaria prevention 2 7 9 29
10. Explain the diagnoses 6 22 28 90
11. Correct timing of ACT 6 24 30 97
Observation score 23 94 0.12 117 39
12. Explain how to take the drugs 6 23 29 94
13. Explain duration of treatment 5 23 28 90
14. Explain proper timing for children treatment 4 21 25 81
15. Give ART suppository to children under 10 kg 2 3 5 16
16. Give correct dose/day 6 24 30 97
Counselling score 1 15 0.07 16 5
17. Give the information about worsening symptoms 0 14 14 45
18. Explain side effects of drugs 1 1 2 6
Total score 53 244 0.03 297
Global score (%) 44.54 59.80 56.36
Non pilot zones: Luang Namtha, Savannakhet, Champasak.
Pilot zones: Sekong, Saravan, Attapeu
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ered as significant.
Verbally-informed consent was obtained from all par-
ticipants. The survey was performed with the permission
of Lao national, regional and village authorities and in
agreement with the Declaration of Helsinki [12]. Ethical
approval from the National Ethical Review Board of
Laos was not sought since the survey did not directly
involve patient interventions beyond national MoH stan-
dard guidelines (Standard treatment guidelines) and rou-
tine national malaria programme activities (i.e. active
case detection surveys are frequently carried out by the
NMCP). Investigators were medical doctors from the
Institut Francophone de Médecine Tropicale (IFMT)
attending a master’s course with special lectures on epi-
demiology, field research and public health. Pre-tests
were performed before conducting the survey.
Results
VHV assessment
This study was performed in January 2007, during the
dry season. Most of the 36 villages had very basic ser-
vices: seven villages (19%) had a private pharmacy and
27 (75%) had a village drug kit provided by the Ministry
of Health (which included only chloroquine, quinine,
and traditional herbal medicines for malaria). Since the
last distribution of ACT from the CMPE (on average
seven months earlier) nearly half of the VHVs had a
shortage of ACT (Table 2).
A total of 36 VHVs and their 720 patients with fever
were assessed. Their characteristics are shown in tables
2 and 3. Of 720 patients, only 31 (4.3%) had a positive
RDT. Except for fever, headache, and chills no other
symptoms were reported to perform a RDT.
The global performance of VHVs was better in PP
than in NPP (Table 1, table 4). Of the 36 VHVs, 75% of
them reported using the village’s drug kit for malaria
but none of these contained ACT. None knew where
ACT could be obtained from, or what its cost was. ACT
was prescribed infrequently either for confirmed or sus-
pected uncomplicated malaria. VHVs from PP gave
chloroquine more frequently than others (p = 0.004)
(Table 2).
Only 16 (44%) VHVs could describe the symptoms of
severe malaria. Coma and convulsions were more fre-
quently related with severe malaria by VHVs of PP (p =
0.09, p = 0.01). Only 15 (42%) had previously seen
patients with severe malaria, three (20%) died, nine
(60%) were treated by the VHVs and eight were referred
to the hospital after the first treatment. Of these eight,
three received artesunate injection, one oral quinine,
one quinine with doxycycline, and four dextrose infu-
sion only. Artesunate injections are not included in the
village’s kit.
Patients’ assessment
Of the 720 patients, 31 (4%) tested positive using the
Paracheck® test, versus 35 (5%) positive with microscopy;
31 (89%) Plasmodium identified were Plasmodium falci-
parum,a n df o u rPlasmodium vivax (Table 5). The sen-
sitivity and specificity of the rapid tests for detecting
Plasmodium falciparum, using the microscopy as a gold
standard, were 74.3% and 99.3%, respectively. The posi-
tive and negative predictive values were 83.9% and
98.7%, respectively.
RDT assessment
VHVs generally reported that RDT was easy to use. The
mean global score rate of the different steps of RDT’s
procedure (10.7 on 15) was rated as good (Table 1).
Two procedures related to checking expiry date and
reporting of results were performed correctly by 50% of
the respondents only. The VHVs from PP had an overall
better score (12.2) than the others (9.1). Two NPP pro-
vinces (Luangnamtha and Savannakhet) yielded an insuf-
ficient score (Table 6 and Figure 2).
ACT prescription for confirmed malaria
The overall mean performance was rated as poor (Table
1). VHVs of PP had a better performance than the
others (score: 60% and 45%, respectively). Only one
PP (Savannakhet Province) reached a satisfactory score
(> 70%).
Of the 18 items, only eight were correctly answered
(Table 1). The best performances were obtained regard-
ing information on ACT dosage (97%) and treatment
duration (97%). These items were related to the actual
treatment given, which can be considered as fairly cor-
rect. Low scores were obtained with regard to disease
history (29%) and patient information about worsening
symptoms (45%) or side effects.
From June to November 2006, 2 188 febrile patients
were tested, of which 35.19% were positive (Table 6).
Patients testing positive for malaria ranged from 5.4% in
NPP to 41.9% in PP, respectively (p < 0.001). They had
a 10-fold chance of testing positive compared to January
((35.19% vs. 4.86%, OR: 10.6, 95%CI: 7.4-15.5, p <
0.001). Correct prescription of ACT ranged from 33% to
97% of confirmed cases. Two PP reached an excellent
level of ACT prescription (Table 6).
Discussion
The study evaluates the knowledge and practice of
recently trained VHVs regarding the new EDAT
malaria national strategy in the Lao PDR. It evaluates
both the practice of RDT and the quality of ACT pre-
scription of a sample of VHVs in 36 villages of six pro-
vinces. It confirms an overall satisfactory performance
of RDT and supports the effectiveness and feasibility
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gaps in knowledge, care of patient and mistreatments
among VHV as providers that have to be addressed.
Overall, pilot provinces yielded better results than
non-pilot provinces regarding care of patients, practice
o fR D Ta n dA C Td i s p e n s a t i o n .
Using RDT, the survey also illustrates the decreasing
rate of malaria morbidity at the village level in provinces
considered as endemic. The incidence of confirmed
malaria was low in northern, central and south-east pro-
vinces during the potential high malaria season. In the
Lao PDR, the number of confirmed cases dropped from
53 156 in 1997 to 18 382, the year of the survey [1].
Transmission was probably very low and probably even
stopped in January (dry season) in these regions [3]. By
contrast, the incidence of malaria was persistent all over
the year in the southern region. This justified the choice
of these regions as pilot provinces. The remote locations
of the survey at the village level probably reflect the rea-
lity of malaria since most of the patients had no other
access to care. The population coverage was not
Table 2 Characteristics and knowledge of VHVs in six provinces of Laos, 2007
Non pilot area
n = 18 (%)
Pilot area
n = 18 (%)
p Total
n=3 6
Sex (female) 0 (0) 3 (16.67) 0.07 3 (8.33)
Age (years)* 34.66 (28.71-40.61) 38.22 (33.75-42.68) 0.3 36.44 (32.86-40.02)
Training on RDT* (days) 2.61 (1.99-3.22) 2.72 (2.07-2.92) 0.7 2.55 (2.19-2.91)
Number of training 1.55 (1.20-1.90) 3.33 (2.15-4.51) 0.004 2.44 (1.78-3.10)
Main indications of MRDT**
-Fever 16 (88.89) 18 (100) 0.1 34 (94.44)
-Headache 14 (77.78) 10 (55.56) 0.1 24 (66.67)
-Chills 13 (72.22) 7 (38.89) 0.04 20 (55.56)
No drug shop in village 12 (66.67) 17 (94.44) 0.03 29 (80.56)
Use village’s kit** 15 (66.67) 15 (83.33) 0.2 27 (75)
Received ACT since (month)* 5.94 (4.30-7.58) 8.05 (7.09-9.01) 0.02 7 (6.02-7.97)
ACT shortage**** 7 (38.89) 10 (55.56) 0.31 17 (47.22)
Treatment for uncomplicated malaria
μ
-Chloroquine 14 (77.78) 4 (22.22) 0.004 18 (50.0)
-Coartem® 3 (16.67) 7 (38.89) 0.13 10 (27.78)
-Paracetamol 0 (0) 6 (33.33) 0.07 6 (16.67)
-Quinine 1 (5.56) 1 (5.56) 1 2 (5.56)
Knows where to get ACT 0 0 0
Cannot describe severe malaria
μμ 11 (61.11) 5(50) 0.5 16 (44%)
Ever diagnosed severe malaria 7 (38.89) 8 (44.44) 0.7 15 (41.67)
Treatment given for severe malaria (n = 15) 3 (42.85) 6 (75) 9 (60)
- Referral 2 (28.57) 6 (75) 0.07 8 (55.33)
- Antimalarial 3 (42.85) 2 (25) 0.4 5 (33.33)
-Artesunate 3 (42.86) 0 0.03 3 (20)
-Quinine
μμμ 0 (0) 2 (25.5) 0.3 1 (6.67)
-Dextrose infusion alone 1 (14.28) 3 (37.5) 0.3 4 (26.67)
Non pilot areas: Luang Namtha. Savannakhet. Champasak.
Pilot areas: Sekong. Saravan. Attapeu.
*Mean and 95% IC = Interval confidence
** reported by VHVs
*** 73% of the VHVs will give chloroquine.
**** occurring since the initial provision of ACT and the survey
μ Similar treatment options for suspected malaria (21 (58%) chloroquine; 9 (25%) Coartem®. 2 (6%) quinine; two associate chloroquine with Coartem® or quinine).
μμμ one received quinine + doxycycline
Table 3 Characteristics of 720 febrile patients seen by
VHVs in 6 Lao provinces in January February 2007
Patients
n = 720 (%)
Sex ratio (F/M) 1.01
Mean age (years) 21.41
Below <15 years 151 (20.97)
RDT positive 31 (4.3)
-<5 years 6 (19.35)
-5-15 years 17 (54.83)
->15 years 8 (25.8)
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dence of malaria in these regions.
Plasmodium vivax represented 12.9% of confirmed
malaria, a rate similar to that previously described,
which suggests no relative decrease of this species in the
Lao PDR, as experienced in Thailand [13,14]. However,
the seemingly uniform lower prevalence of vivax malaria
in endemic provinces might be partly because of the
tendency of P. vivax to achieve and maintain lower-den-
sity parasitaemia, and the inverse relation between diag-
nostic sensitivity and parasitaemia count [15]. The
detection of low level asymptomatic and mixed species
infections with conventional light microscopy is limited
and the RDT adopted in the Lao PDR does not diagnose
P. vivax infection. Albeit the many challenges of intro-
ducing P. vivax diagnosis and treatment in Laos, the
CMPE should consider a preliminary introduction of a
P. vivax RDT.
VHVs are key persons to improving EDAT at village
level in countries with poor health facilities. Until
recently, most patients with fever were treated for
malaria, based only on clinical suspicion by the VHVs,
and most VHVs and pharmacy owners lacked basic
knowledge of malaria management [2]. As a result,
malaria tended to be overestimated and many patients
were probably wrongly treated (infectious diseases such
as rickettsia, typhoid or leptospirosis mimicking malaria
are common in Laos) [16,17]. The survey supports the
positive impact of training VHVs in PP, which yielded a
generally better score of performance than others
regarding both RDT assessment and ACT prescription.
More training focussing on prevention of disease, wor-
sening symptoms, and information of the patients are
suggested for both groups of provinces.
Analysis within the provinces reveals a high discre-
pancy between them: only one province (Saravan) had
an excellent score of achievement, but two out of the
six had a very poor level. Comparing RDT at village
level with the gold standard microscopy at the provincial
level yielded predictive values above 80%. This con-
firmed the accuracy of RDT reading among the VHVs
surveyed at the village level, but results were less
Table 4 Malaria rapid test (Paracheck®) evaluation in six provinces of Laos, 2007
N° Paracheck® Pf (Procedures) Non pilot provinces
n = 320
(%) Pilot Provinces
n = 320
(%) p Total
n=720
(%)
1 Preparation 152 (42.2) 298.0 (82.8) <0.001 450 (62.5)
2 Look at the expiry date 20 (5.6) 122.0 (33.9 <0.001 142 (19.7)
3 Open the package properly 315 (87.5) 327.0 (90.8) 0.1 642 (89.2)
4 Check desiccant and record 117 (32.5) 291.0 (80.8) <0.001 408 (56.7)
5 Clean middle or ring finger with the alcohol pad 329 (91.4) 341.0 (94.7) 0.1 670 (93.1)
6 Wipe off alcohol with gauze 194 (53.9) 233.0 (64.7) 0.04 427 (59.3)
7 Prick finger with sterile lancet (pick the side of finger) 355 (98.6) 339.0 (94.2) 0.002 694 (96.4)
8 Discard blood lancet 211 (58.6) 257.0 (71.4) <0.001 468 (65.0)
9 Squeeze one blood drop out 211 (58.6) 328.0 (91.1) <0.001 539 (74.9)
10 Collect blood with pipette (touch the surface of the blood drop) 224 (62.2) 330.0 (91.7) <0.001 554 (76.9)
11 Apply blood in sample well 230 (63.9) 340.0 (94.4) <0.001 570 (79.2)
12 Discard pipette 241 (66.9) 266.0 (73.9) 0.05 507 (70.4)
13 Put buffer - 6 drops in ‘B’ well 283 (78.6) 340.0 (94.4) <0.001 623 86.5
14 Wait for 15 min and interpret correctly 272 (75.6) 291.0 (80.8) 0.01 563 78.2
15 Record results 123 (34.2) 235.0 (65.3) <0.001 358 49.7
Total score/15 9.1 12.2 10.7
Table 5 Distribution of 720 suspected malaria patients after microscopy and MRDT in Laos, 2007
Microscopy Positive
n = 35 (4.8%)
Microscopy Negative
n = 685 (95.2%)
Total
n = 720 (100%)
RDT
- Positive 26 (74.2) 5 (0.7) 31 (4.3)
- Negative 9 (25.7) 680 (99.2) 689 (95.69)
Parasites
-P. falciparum 26 (74.28) 5 (0.72) 31 (4.3)
-P. vivax 0 4 (0.58) 4 (0.55)
Parasites mean density/μL* 618 (48-42400) 0 -
* Geometric mean (and range); 11 (37.11%) were below 500 parasites/μl
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lar monitoring and quality control [7].
A possible limitation of this survey is that it was con-
ducted during the low transmission season. The peak
malaria transmission months in Laos are from July to
October. However, the survey shows that malaria was
still acute in two settings (Attapeu and Sekong) during
the non-peak seasons. This study attempted to take this
into consideration by including a retrospective survey
covering six months of the transmission period. This
later survey had the usual limitations of retrospective
survey (incomplete files, omissions, inaccuracy).
To decrease the possibility of a bias due to the attrac-
tiveness of the medical team performing the survey, and
t h ep o s s i b i l i t yo ft h eV H V sshowing their practice in
their best light, VHVs were informed that they should
continue their work as usual and that their identity
would remain confidential. Nevertheless, the survey may
probably have slightly overestimated the performance of
VHVs, mostly for the first patients.
In fact, of the 720 febrile patients seen in January, only
4.8% had malaria parasites and 4.3% had a positive RDT.
This potentially saves around 689 malarial treatments
that would have previously been given in the absence of
a confirmed diagnosis, and the use of ineffective chloro-
quine increasing the drug pressure [6]. The RDT strat-
egy allowed to dramatically reduce the number of
unnecessary cases of malaria treatment and potentially
allows focusing better on other diseases. The benefits of
RDT strategy were also well supported by the retrospec-
tive survey in the high malaria season, which revealed a
35% rate of malaria cases among the 2,188 suspected
patients. This allowed the saving of 1 418 malaria treat-
ments enabling the patient to save money, an important
issue in a country were two-thirds of the population
lives on less that USD 2 a day [18].
The low use of ACT despite the new policy is of con-
cern. VHVs still prescribed non-ACT and ineffective
chloroquine. Only a quarter of them would choose
ACT. This signals the need for further information/
Table 6 Evaluation of malaria patients treated by VHV in Laos (register book June - November 2006)
Non Pilot Provinces (NPS) Pilot Provinces (PS) Total
LNT n(%) SVK n(%) CPS n(%) Total n(%) SK n(%) SRV n(%) ATP n(%) Total n(%) n(%)
Patients tested 6 401 98 505 302 510 871 1683 2188
RDT positive (%)* 6 (100) 50 (12) 8 (8) 64 (12) 134 (44) 201 (39) 371 (43) 706 (42) 770 (35)
- <5 years positive (%)** 0 12 (24) 0 12 (18) 29 (21.6) 7 (3.5) 304 (81.9) 340 (48) 352 (45.9)
ACT treatment (%)*** 6 (100) 16 (33) 5 (62) 27 (42) 87 (65) 195 (97) 371 (100) 653 (92) 680 (88)
LNT: Luang Namtha, SVK: Savannakhet, CPS: Champasak, SK: Sekong, SRV: Saravan, ATP: Attapeu
RDT: rapid diagnostic test, ACT: arteminsin based combination treatment
* More patients tested positive in pilot provinces (p < 0.000)
** % of positive children under 5 years
*** Correct: Artesunate suppository for children and ACT for adult. More ACT treatment were given in pilot provinces (p < 0.000)
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Figure 2 Performance of VHVs using MRDT in 6 provinces of Laos.
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Page 8 of 10training of VHVs to ensure compliance with the
national treatment strategy.
Paracheck® and Coartem® are supplied not through the
MoH village drug kits but through a separate vertical
distribution system from the CMPE, which will probably
improve after the first years of implementation. Timely
reporting on consumption and stock levels by VHV may
require an incentive program if out-of-stock situations
are to be avoided.
Detecting symptoms of severe malaria and starting
early treatment are key strategies to decreasing malaria
related mortality. Despite recent training, VHVs still
lacked knowledge on severe malaria detection and treat-
ment [7]. Less than 20% of the VHVs identified 3-4 of
the criteria of severe malaria. Only 41% ever diagnosed
severe malaria. A total of 4 752 cases of malaria in 2006
were hospitalized (a proxy for severe malaria) in Laos,
of which 3 910 (82%) were reported in the six surveyed
provinces (CMPE, unpublished data). Since only half of
the severe malaria cases were referred in the survey, this
suggests reconsidering and probably doubling the esti-
mation of severe malaria in Laos.
Additionally, in this study, the rate of mortality among
severe malaria patients reached 20% at the village level.
Hence, the figure of mortality obtained in only 36 vil-
lages suggests a probable underestimation of the official
malaria deaths (21 reported deaths in 2006) [9].
Pre-referral treatment was only performed for half
the severe malaria cases. Of them, only five (55%)
received an anti-malarial treatment. Interestingly,
injectable artesunate was not available in the village
kits and the CMPE, as per guidelines, distributed this
drug only to district and provincial hospitals. It can be
hypothesized that some VHVs were given vials of arte-
sunate from the CMPE programme. In fact, VHVs did
not know where to get ACT or what it cost. They may
also be vulnerable to ambulant drug vendors who sell
fake or substandard artemisinin based anti-malarials, a
major threat in Asia [19,20]. More studies should
focus on the alternative treatments given at the village
level and assess their effectiveness. VHVs need to
know that counterfeit and sub-standard anti-malarials,
including artesunate monotherapies, are widespread
and that a safe source of ACT would be the national
malaria programme. These results question the avail-
ability of potent anti-malarial treatment at the village
level where one cannot expect a high rate of referral to
a higher health care facility.
Perspectives
RDT is easy to use, reliable and an appropriate test for
use in the field by VHVs in the Lao PDR. Results also
suggest more training to improve EDAT. Training and
monitoring of user behaviour have to be reinforced
especially in the provinces with poor success rates.
Appropriate training and instruction have to be adapted
to each province. Provinces with stable or decreasing
transmission of malaria should be trained in the treat-
ment of non-malaria fevers (dengue, arbovirosis but also
infectious diseases such as leptospirosis, melioidosis,
typhoid, rickettsia which are common but with scarce
prevalence data at the national level) [16-18,21]. In
endemic provinces the problem may be to scale up pre-
vention and care of patients with appropriate diagnosis
and early treatment. Current decrease of malaria and
the emergence of dengue fever outbreaks have to be
regularly assessed and monitored in the countryside.
Conclusion
RDT and ACT, the new tools for EDAT in Laos are
effective and well understood by VHVs. The survey con-
firms the ability of VHVs to use RDT, but underlines
persistent gaps in knowledge, care of patients and treat-
ment, which warrant further follow up, and training.
The simplification brought by EDAT at village level will
probably help the control of malaria, together with
other strategy programmes.
Conflict of interests
The authors declare that they have no competing
interests.
Funding
Global Fund against aids, tuberculosis and malaria
through the CMPE of Lao PDR funded the survey
Acknowledgements
We thank CMPE staff, IFMT staff and all the people who participated in
collecting data during the surveys and all the participating VHVs, patients
and families, and the Lao authorities. We thank Dr Bouasy, Dr Viengsay, Dr
Keophouphaphone from the CMPE and Dr Manisak and the staff of National
Institute of Public Health for help during the survey preparation and data
collection.
We thank Dr. Philaysak Naphayvong and Dr Phengta Vongphrachanh for
facilitating the relationship with the Lao Authorities during the preparation
of the survey. We also thank Dr B Hongvankhame, V Navaviseth, the
provincial and district malaria stations in the survey areas for their helpful
contribution and collaboration during the survey. We thank Percy Aaron for
editing the manuscript. We thank the Lao National Health Authorities for
their support, WHO for valuable advice, the Global Fund for making available
the funds to CMPE to fund the surveys and IFMT staff for their
administrative and technical support.
Author details
1Institut de la Francophonie pour la Médecine Tropicale, Vientiane, BP 9519,
Lao PDR.
2World Health Organization, Vientiane Lao PDR.
Authors’ contributions
HB wrote the manuscript and is responsible for the overall coordination,
design and analysis of the surveys in the Lao PDR. He is also guarantor. HB
and GD designed the survey with the participation of PV and KT. PV and KT
collected the data and performed the first analysis under HB’s monitoring
with regular advice from GD. HB performed the final analysis. GD, PV, KT, JPR
and HB discussed the results. PV and KT wrote the first report with the
Phommanivong et al. Malaria Journal 2010, 9:347
http://www.malariajournal.com/content/9/1/347
Page 9 of 10participation of GD, JPR and HB. All authors contributed to the writing of
the paper and read the final version.
Received: 6 July 2010 Accepted: 1 December 2010
Published: 1 December 2010
References
1. World malaria report 2009. [http://www.who.int/malaria/publications/atoz/
9789241563901/en/index.html].
2. Mayxay M, Pongvongsa T, Phompida S, Phetsouvanh R, White NJ,
Newton PN: Diagnosis and management of malaria by rural community
health providers in the Lao People’s Democratic Republic (Laos). Trop
Med Int Health 2007, 12:540-546.
3. Jorgensen P, Nambanya S, Gopinath D, Hongvanthong B,
Luangphengsouk K, Bell D, Phompida S, Phetsouvanh R: High
heterogeneity in Plasmodium falciparum risk illustrates the need for
detailed mapping to guide resource allocation: a new malaria risk map
of the Lao People’s Democratic Republic. Malar J 2010, 9:59.
4. Guthmann JP, Kasparian S, Phetsouvanh R, Nathan N, Garcia M,
Phompida S, Brockman A, Gastellu M, Legros D: The efficacy of
chloroquine for the treatment of acute, uncomplicated, Plasmodium
falciparum malaria in Laos. Ann Trop Med Parasitol 2002, 96:553-557.
5. Schwobel B, Jordan S, Vanisaveth V, Phetsouvanh R, Christophel EM,
Phompida S, von Sonnenburg F, Jelinek T: Therapeutic efficacy of
chloroquine plus sulphadoxine/pyrimethamine compared with
monotherapy with either chloroquine or sulphadoxine/pyrimethamine
in uncomplicated Plasmodium falciparum malaria in Laos. Trop Med Int
Health 2003, 8:19-24.
6. Mayxay M, Khanthavong M, Lindegardh N, Keola S, Barends M,
Pongvongsa T, Yapom R, Annerberg A, Phompida S, Phetsouvanh R,
White NJ, Newton PN: Randomized comparison of chloroquine plus
sulfadoxine-pyrimethamine versus artesunate plus mefloquine versus
artemether-lumefantrine in the treatment of uncomplicated falciparum
malaria in the Lao People’s Democratic Republic. Clin Infect Dis 2004,
39:1139-1147.
7. Mayxay M, Newton PN, Yeung S, Pongvongsa T, Phompida S,
Phetsouvanh R, White NJ: Short communication: An assessment of the
use of malaria rapid tests by village health volunteers in rural Laos. Trop
Med Int Health 2004, 9:325-329.
8. Rennie W, Phetsouvanh R, Lupisan S, Vanisaveth V, Hongvanthong B,
Phompida S, Alday P, Fulache M, Lumagui R, Jorgensen P, Bell D, Harvey S:
Minimising human error in malaria rapid diagnosis: clarity of written
instructions and health worker performance. Trans R Soc Trop Med Hyg
2007, 101:9-18.
9. WHO: Lao People’s Democratic Republic Country profile 2010.
10. Vythilingam I, Sidavong B, Chan ST, Phonemixay T, Vanisaveth V, Sisoulad P,
Phetsouvanh R, Hakim SL, Phompida S: Epidemiology of malaria in
Attapeu Province, Lao PDR in relation to entomological parameters.
Trans R Soc Trop Med Hyg 2005, 99:833-839.
11. Beaver C, Viengxay V, Gobinath D: Option Appraisal of Village Health Worker
Incentive Program Lao PDR; 2010.
12. Declaration of Helsinski. [http://www.cirp.org/library/ethics/helsinki/].
13. Childs DZ, Cattadori IM, Suwonkerd W, Prajakwong S, Boots M:
Spatiotemporal patterns of malaria incidence in northern Thailand. Trans
R Soc Trop Med Hyg 2006, 100:623-631.
14. Mayxay M, Newton PN, Khanthavong M, Tiengkham P, Phetsouvanh R,
Phompida S, Brockman A, White NJ: Chloroquine versus sulfadoxine-
pyrimethamine for treatment of Plasmodium falciparum malaria in
Savannakhet Province, Lao People’s Democratic Republic: an assessment
of national antimalarial drug recommendations. Clin Infect Dis 2003,
37:1021-1028.
15. Mueller I, Galinski M, Baird J, Carlton J, Kochar D, Alonso P, delPortillo H:
Key gaps in the knowledge of Plasmodium vivax, a neglected human
malaria parasite. Lancet Inf Dis 2009, 9:555-556.
16. Phongmany S, Rolain JM, Phetsouvanh R, Blacksell SD, Soukkhaseum V,
Rasachack B, Phiasakha K, Soukkhaseum S, Frichithavong K, Chu V,
Keolouangkhot V, Martinez-Aussel B, Chang K, Darasavath C, Rattanavong O,
Sisouphone S, Mayxay M, Vidamaly S, Parola P, Thammavong C,
Heuangvongsy M, Syhavong B, Raoult D, White NJ, Newton PN: Rickettsial
infections and fever, Vientiane, Laos. Emerg Infect Dis 2006, 12:256-262.
17. Phongmany S, Phetsouvanh R, Sisouphone S, Darasavath C,
Vongphachane P, Rattanavong O, Mayxay M, Ramsay AC, Blacksell SD,
Thammavong C, Syhavong B, White NJ, Newton PN: A randomized
comparison of oral chloramphenicol versus ofloxacin in the treatment of
uncomplicated typhoid fever in Laos. Trans R Soc Trop Med Hyg 2005,
99:451-458.
18. Lao PDR at a glance. [http://devdata.worldbank.org/AAG/lao_aag.pdf].
19. Newton PN, McGready R, Fernandez F, Green MD, Sunjio M, Bruneton C,
Phanouvong S, Millet P, Whitty CJ, Talisuna AO, et al: Manslaughter by fake
artesunate in Asia–will Africa be next? PLoS Med 2006, 3:e197.
20. Newton PN, Fernandez FM, Plancon A, Mildenhall DC, Green MD, Ziyong L,
Christophel EM, Phanouvong S, Howells S, McIntosh E, Proux S,
Christophel EM, Malenga G, Singhasivanon P, Bojang K, Kaur H, Palmer K,
Day NP, Greenwood BM, Nosten F, White NJ: A collaborative
epidemiological investigation into the criminal fake artesunate trade in
South East Asia. PLoS Med 2008, 5:e32.
21. Syhavong B, Rasachack B, Smythe L, Rolain JM, Roque-Afonso AM,
Jenjaroen K, Soukkhaserm V, Phongmany S, Phetsouvanh R, Soukkhaserm S,
Thammavong T, Mayxay M, Blacksell SD, Barnes E, Parola P, Dussaix E,
Raoult D, Humphreys I, Klenerman P, White NJ, Newton PN: The infective
causes of hepatitis and jaundice amongst hospitalised patients in
Vientiane, Laos. Trans R Soc Trop Med Hyg 2010, 104:475-83.
doi:10.1186/1475-2875-9-347
Cite this article as: Phommanivong et al.: An assessment of early
diagnosis and treatment of malaria by village health volunteers in the
Lao PDR. Malaria Journal 2010 9:347.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Phommanivong et al. Malaria Journal 2010, 9:347
http://www.malariajournal.com/content/9/1/347
Page 10 of 10